JOBSTRESS-OPH: JOB STRESS in OPHthalmology Physicians and Residents

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Recruiting
CT.gov ID
NCT04959838
Collaborator
University Clermont Auvergne (UCA), Clermont-Ferrand, France (Other), LaPSCO laboratory, UMR CNRS 6024, Clermont-Ferrand, France (Other)
30
1
1
47.8
0.6

Study Details

Study Description

Brief Summary

Ophthalmology physicians and residents work under stress conditions during night emergency ophthalmology shifts. Under time pressure, that is a characteristic of the urgency of care, they must use all their cognitive resources to make an accurate diagnosis and to provide accurate decisions, with sometimes surgical emergency acts. In addition, in France, they work at night following by an usual day work, and they can also work 48 consecutive hours during weekends, followed by a work day … i.e. 60 consecutive hours of work … Long working hours with a short recovery time has been demonstrated to be a major factor of stress and fatigue. Even if not demonstrated on ophthalmologists, those working conditions may contribute to symptoms of mental exhaustion and physical fatigue (sleep deprivation), often accompanied by a loss of motivation at work. This may leads to a feeling of loss of time control; stress can also distort the perception of time and leads to hasty actions or delayed decision-making. The combined effects of stress, feelings of loss of time control, and fatigue necessarily have an impact on work performance and work quality, with a high risk of medical error. Moreover, prolonged stress may expose ophthalmologists to a higher risk of multiple diseases, predominantly systemic inflammation and coronary heart disease.

The main hypothesis is that prolonged work (up to 60 consecutive working hours) may impact on HRV, comparatively to a typical working day.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Impact of prolonged work
N/A

Detailed Description

The JOBSTRESS.OPH protocol was designed to study the impact of prolonged work (up to 60 consecutive working hours) on HRV, comparatively to a typical working day. Each residents and / or ophthalmology physicians participates up to a maximum of 5 times. Participants wears a heart rate belt and a watch that measures physical activity and skin conductance for 34 hours straight. Participants only wears an EEG monitor while sleeping to assess its quality. At the end of the evaluation session, a simulator test mimicking the successive stages of cataract surgery is performed, as well as the performance of saliva tests. Short quality of life assessment questionnaires are completed at the start and end of the day, supplemented by a general questionnaire completed only once during the study.

Statistical analysis will be performed using Stata software (v15, Stata-Corp, College Station, US). Categorical parameters will be described in terms of numbers and frequencies, whereas continuous variables will be expressed as mean and standard deviation or median and [inter-quartile range] according to statistical distribution. All statistical tests will be two-sided and p<0.05 will be considered significant. Graphic representations will be complete presentations of results.

Investigators process multivariate physiological series (HRV, SC, biomarkers) in order to build a stress index. For such multivariate physiological series, investigators first use change point analysis on each univariate series in order to get clusters with constant parameters, then investigators use classification algorithm on the constant parameters obtained in first step in order to obtain different classes corresponding to different levels of stress. Eventually, investigators obtain at each time the level of stress and can compare it to the environmental conditions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Monitoring of JOB STRESS Related to Night Shifts in OPHthalmology Physicians and Residents
Actual Study Start Date :
Jul 6, 2021
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ophthalmology physicians and residents

Ophthalmology physicians and residents will be followed during 34h, from 8 am to 6 pm the following day,in five different conditions: Control day (no work) Typical working day Working day + one night shift Emergency working day + two consecutive night shifts Night shift.

Behavioral: Impact of prolonged work
Evaluate the impact of prolonged work (up to 60 consecutive hours) on the surgical capacities evaluated on a simulator, as well as on stress markers (questionnaires, saliva assays, skin conductance, quality of sleep) compared to a standard day.

Outcome Measures

Primary Outcome Measures

  1. Heart rate variability [During 34 hours in the five different conditions]

    HRV will be explored in time and frequency domains Abrupt changes in HRV signals will be explored.

Secondary Outcome Measures

  1. change in stress levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of stress using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  2. change in stress levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of stress using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  3. change in fatigue levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of fatigue using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  4. change in fatigue levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of fatigue using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  5. change in burnout levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of burnout using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  6. change in burnout levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of burnout using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  7. change in depression levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of depression using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  8. change in depression levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of depression using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  9. change in anxiety levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of anxiety using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  10. change in anxiety levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of anxiety using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  11. change in "Job demand control support" levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of job demand, job control and support levels using visual analogue scale of 100 mm, from 0 to 100. Higher scores of demand mean a worse level. Higher scores of control and support mean a better level.

  12. change in "Job demand control support" levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of job demand, job control and support levels using visual analogue scale of 100 mm, from 0 to 100. Higher scores of demand mean a worse level. Higher scores of control and support mean a better level.

  13. change in "Effort reward imbalance" levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of effort reward imbalance using visual analogue scale of 100 mm, from 0 to 100. Higher scores of mean a better outcome level.

  14. change in "Effort reward imbalance" levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of effort reward imbalance using visual analogue scale of 100 mm, from 0 to 100. Higher scores of mean a better outcome level.

  15. change in work addiction levels [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of work addiction using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  16. change in work addiction levels [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of work addiction using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  17. change in sleep quality [at 8am, beginning of the 34 hours follow-up, in the five different conditions]

    measure of sleep quality using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  18. change in sleep quality [at 6pm, end of the 34 hours follow-up, in the five different conditions]

    measure of sleep quality using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.

  19. Saliva biomarkers cortisol [baseline of the 34 hours procedure, in the five different conditions]

    measure on Cortisol

  20. Saliva biomarkers cortisol [24hours after the beginning of the procedure, in the five different conditions]

    measure on Cortisol

  21. Saliva biomarkers dheas [baseline of the 34 hours procedure, in the five different conditions]

    measure on dheas

  22. Saliva biomarkers dheas [24 hours after the beginning of the procedure, in the five different conditions]

    measure on dheas

  23. Saliva biomarkers lgAs [baseline of the 34 hours procedure, in the five different conditions]

    measure on lgAs

  24. Saliva biomarkers lgAs [24 hours after the beginning of the procedure, in the five different conditions]

    measure on lgAs

  25. Saliva biomarkers Leptine [baseline of the 34 hours procedure, in the five different conditions]

    measure on Leptine

  26. Saliva biomarkers Leptine [24 hours after the beginning of the procedure, in the five different conditions]

    measure on Leptine

  27. Saliva biomarkers Ghrelin [baseline of the 34 hours procedure, in the five different conditions]

    measure on Ghrelin

  28. Saliva biomarkers Ghrelin [24 hours after the beginning of the procedure, in the five different conditions]

    measure on Ghrelin

  29. Declared level of physical activity [once at 8am, at the beginning of the procedure]

    Physical activity is assessed with one question

  30. Level of physical activity [during 34 hours, in the five different conditions]

    Physical activity is assessed with a 3-Axis accelerometer

  31. Level of sedentary [once at 8am, at the beginning of the procedure]

    Sedentary is assessed regarding the time spent sitting assessed with one question

  32. Food intake [34 hours recording, in the five different conditions]

    assessing food intake with ingesta

  33. Sick leave [once at 8am, at the beginning of the procedure]

    assessing the number of absence days the previous 6 months using a questionnaire

  34. Height [once at 8am, at the beginning of the procedure]

    measure of height in cm using a questionnaire

  35. Weight [once at 8am, at the beginning of the procedure]

    measure of weight in kilograms using a questionnaire

  36. Age [once at 8am, at the beginning of the procedure]

    measure of age in years using a questionnaire

  37. Gender [once at 8am, at the beginning of the procedure]

    measure of gender using a questionnaire

  38. Qualification [once at 8am, at the beginning of the procedure]

    measure of qualification using a questionnaire

  39. Personal status [once at 8amat the beginning of the procedure]

    measure of personal status using a questionnaire

  40. Lifestyle [once at 8am, at the beginning of the procedure]

    Assessing factors related to lifestyle as smoking, alcohol and coffee consumption using a questionnaire

  41. Skin conductance [during 34 hours , in the five different conditions]

    measure of the skin conductance using Wrist band electrodes

  42. Sleep quality [measure for about 7 hours the night of the control day (no work)]

    measure of sleep quality using Sleep profiler

  43. Sleep quality [measure for about 7 hours during the night of the typical working day]

    measure of sleep quality using Sleep profiler

  44. Surgical performance [Once at 6pm, at the end of the 34 hours follow-up , in the five different conditions]

    assessing surgical performance using a high-end virtual reality simulator for intraocular surgery training

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ophthalmologists defined as physicians who completed the ophthalmology DES (Specialized studies diploma), as well as ophthalmology residents defined as a resident registered in the ophthalmology DES working during the inclusion period in the ophthalmology department of the university hospital center of Clermont-Ferrand.

  • Ability to give a written informed consent to participate in research.

  • Affiliation to a social security system.

  • Age between 18 and 65 years old

Exclusion Criteria:
  • Participant refusal to participate

  • Children under the age of 18, pregnant and breastfeeding women, protected adults (individuals under guardianship by court order), adults deprived of their liberty.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU clermont-ferrand Clermont-Ferrand France

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand
  • University Clermont Auvergne (UCA), Clermont-Ferrand, France
  • LaPSCO laboratory, UMR CNRS 6024, Clermont-Ferrand, France

Investigators

  • Principal Investigator: Frédéric DUTHEIL, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT04959838
Other Study ID Numbers:
  • RBHP 2020 DUTHEIL 2
  • 2020-A03231-38
First Posted:
Jul 13, 2021
Last Update Posted:
Jun 6, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 6, 2022